Jean-Frédéric Blanc

4PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 21, 2025
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study.

Jean-Frédéric Blanc, Mohamed Bouattour, Ludovic Gauthier

|Mar 23, 2021
Proteomic Profiling of Hepatocellular Adenomas Paves the Way to Diagnostic and Prognostic Approaches.

Cyril Dourthe, Céline Julien, Sylvaine Di Tommaso

|Jun 04, 2020
ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice.

Margaux Sala, Delphine Gonzales, Thierry Leste-Lasserre

|May 20, 2020
Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma.

Robin K Kelley, Patrick Mollon, Jean-Frédéric Blanc

Pageof 1

Frequent Collaborators

2 joint publications

Paulette Bioulac-Sage

2 joint publications

Frédéric Saltel

2 joint publications

Anne-Aurélie Raymond

2 joint publications

Charles Balabaud